AVNRT treatment overview

Jump to navigation Jump to search

AVNRT Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating AVNRT from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diaagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Overview

Medical Treatment

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

AVNRT treatment overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of AVNRT treatment overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on AVNRT treatment overview

CDC on AVNRT treatment overview

AVNRT treatment overview in the news

Blogs on AVNRT treatment overview

Directions to Hospitals Treating AVNRT

Risk calculators and risk factors for AVNRT treatment overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

An episode of supraventricular tachycardia (SVT) due to AVNRT can be terminated by any action that transiently blocks the AV node. Various methods are possible.

Patient position

Vagal maneuvers

Medical Therapy

Cardioversion

Electrophysiologic Testing and Radiofrequency Ablation

Prevention

Template:WH Template:WS CME Category::Cardiology